A Study of Capmatinib in Lung Cancer Patients
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Non-small Cell Lung Cancer MET exon 14 skipping mutation High MET amplification Neoadjuvant Prior to surgery Adjuvant After surgery INC280 MET inhibition adult capmatinib Carcinoma, Non-Small-Cell Lung
Lead Scientist at UC Davis
- Li Tianhong
Associate Professor, Hematology and Oncology. Authored (or co-authored) 65 research publications